Inflammatory markers and Type 2 diabetes mellitus as prognostic risk factors in low-risk bladder cancer

BJU Int. 2023 Aug;132(2):154-156. doi: 10.1111/bju.16026. Epub 2023 Apr 23.

Authors

Nicola Frego^{1

2}, Roberto Contieri^{1

2}, Pietro Diana^{1

2}, Stefano Mancon^{1

2}, Piergiuseppe Colombo^{3

2}, Massimo Lazzeri¹, Nicolo Maria Buffi^{1

2}, Paolo Casale¹, Rodolfo Hurle¹

Affiliations

¹ Department of Urology, IRCCS Humanitas Research Hospital, Milan, Italy.
² Department of Biomedical Sciences, Humanitas University, Milan, Italy.
³ Department of Pathology, IRCCS Humanitas Research Hospital, Milan, Italy.

PMID: 37017610
DOI: 10.1111/bju.16026

No abstract available

MeSH terms

Diabetes Mellitus, Type 2* / complications
Humans
Prognosis
Risk Factors
Urinary Bladder Neoplasms*